After the transaction, Wood Mark's stake was reported as 25,646 shares of Biomarin Pharmaceutical Inc stock. In addition, Wood Mark performed several other transactions, including using transaction codes 'M' (exercise, usually of options).
As noted on January 24, 2013, Wood Mark's sale was done directly over 2 transactions on January 22, 2013. The share price ranged from $54.81 to $55 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Wood Mark has sold a total of 46,749 shares of Biomarin Pharmaceutical Inc, proceeds from the sale totaled $2,570,702. Over the same time period, Wood Mark has purchased no shares of Biomarin Pharmaceutical Inc stock. Wood Mark has also performed other transactions including exercise of options .
Let's take a quick, high-level look at insider trading at Biomarin Pharmaceutical Inc over the past 12 months. A total of 1,361,132 shares of Biomarin Pharmaceutical Inc stock was sold by insiders, totaling $57,436,047. Over the same time 12 month time period, no shares of Biomarin Pharmaceutical Inc were purchased by company insiders.
To view the complete SEC Filing: Biomarin Pharmaceutical Inc Form 4 (Insider Trading) SEC Filing